|
ACAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.844360E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.690800E-01 |
| Normal-vs-Stage2 |
9.401800E-01 |
| Normal-vs-Stage3 |
2.633700E-02 |
| Normal-vs-Stage4 |
3.232200E-02 |
| Stage1-vs-Stage2 |
6.391800E-01 |
| Stage1-vs-Stage3 |
3.913900E-02 |
| Stage1-vs-Stage4 |
8.185900E-02 |
| Stage2-vs-Stage3 |
1.081830E-01 |
| Stage2-vs-Stage4 |
1.079020E-01 |
| Stage3-vs-Stage4 |
8.477400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.551980E-01 |
| Normal-vs-AfricanAmerican |
7.262800E-01 |
| Normal-vs-Asian |
1.313020E-01 |
| Caucasian-vs-AfricanAmerican |
5.216200E-01 |
| Caucasian-vs-Asian |
7.253600E-01 |
| AfricanAmerican-vs-Asian |
3.888800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.348230E-01 |
| Normal-vs-Female |
2.802600E-01 |
| Male-vs-Female |
3.453000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.946800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.092220E-01 |
| Normal-vs-Age(61-80Yrs) |
1.588760E-01 |
| Normal-vs-Age(81-100Yrs) |
1.390620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.760000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.151000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.693200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.676600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.578400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.070200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.332240E-01 |
| Classical-VS-Follicular |
7.223600E-01 |
| Classical-VS-Other |
1.752590E-01 |
| Classical-VS-Normal |
4.204200E-01 |
| Tall-VS-Follicular |
1.115040E-01 |
| Tall-VS-Other |
5.351000E-01 |
| Tall-VS-Normal |
4.716300E-02 |
| Follicular-VS-Other |
2.523200E-01 |
| Follicular-VS-Normal |
7.184400E-01 |
| Other-VS-Normal |
7.127900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.941220E-01 |
| Normal-vs-N1 |
2.456300E-02 |
| N0-vs-N1 |
1.926600E-01 |
|
|
